To further validate the association between HMGCL expression and HCC patients’ prognosis, we performed IHC utilizing a tissue microarray (TMA) from 252 HCC tissues from cohort 1 (Fig. 1C, D) with clinicopathological information that listed in Table 1. This evidence concerns the gene HMGCL and hepatocellular carcinoma.